• AAPL 183.36
  • TSLA 181.14
  • AMZN 186.235
  • MSFT 406.8
  • INTC 30.9
  • EURUSD 1.0767
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. MC /
  3. PHM.MC

Pharma Mar S.A. (PHM MC) stock market data APIs

€31.2 0.06(0.2%) as of May 3, 2024

Pharma Mar S.A. Financial Data Overview

31.14
31.2
-
31.66
30.92
26.16-43.92
546 M
283.2727
17 508 K
158 M
-0.3866
0.021
-0.08
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'PHM',
Type: 'Common Stock',
Name: 'Pharma Mar S.A.',
Exchange: 'MC',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Spain',
CountryISO: 'ES',
OpenFigi: NULL,
ISIN: 'ES0169501022',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Pharma Mar S.A. Fundamental Data is available in our Financial Data APIs

  • Net Revenue 158 M
  • EBITDA -1 146 000
  • Earnings Per Share 0.11
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Pharma Mar S.A. Earnings via APIs

  • Latest Release 2024-02-29
  • EPS/Forecast NaN

Get Pharma Mar S.A. End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Pharma Mar S.A. latest news via APIs

Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants

- The final results of the APLICOV-PC study (Phase I-II), which were initially released last May and which the Company shared with the scientific community, demonstrate the safety of plitidepsin's use...
  • EUROPEAN MOLECULAR BIOLOGY ORGANIZATION
  • LIFE SCIENCE ALLIANCE
  • OMICRON
  • PHARMAMAR
  • PLITIDEPSIN
  • POTENT ANTIVIRAL ACTIVITY
  • VARIANTS

Jazz Pharmaceuticals Announces U.S. FDA Accelerated Approval of Zepzelca™ (lurbinectedin) for the Treatment of Metastatic Small Cell Lung Cancer

Approval represents an important advance for adult patients whose metastatic SCLC has progressed on or after platinum-based chemotherapy Zepzelca is approved under accelerated approval based on overa...
  • DISEASE PROGRESSION
  • HEALTHCARE PROVIDER
  • JAZZ PHARMACEUTICALS
  • PHARMAMAR
  • PLATINUM-BASED CHEMOTHERAPY
  • SCLC PATIENTS
  • ZEPZELCA
Do you have any questions?
support@eodhistoricaldata.com